tm logo

Trademark Search

Owners

GENENTECH, INC.

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
Dead/Abandoned
ABANDONED - EXPRESS

express

on 22 Sep 2016

Last Applicant/ Owned by

1 DNA WAY

SOUTH SAN FRANCISCO

CA

940804990

Serial Number

86850524 filed on 16th Dec 2015

Registration Number

N/A

Correspondent Address

GENENTECH, INC.

1 DNA WAY

SOUTH SAN FRANCISCO, CA 94080-4990

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG

Pharmaceutical oncology preparations The mark consists of THE WORD TECENTRIQ WITH ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG UNDER IT. THE FIRST T IN TECENTRIQ HAS THREE ARROWS POINTING INWARDS IN A CIRCLE ABOVE IT IN THE UPPER LEFT HAND CORNER. Color is not claimed as a feature of the mark.

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical oncology preparations

Mark Details


Serial Number

No 86850524

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

24.15.04 -

Arrowheads

24.15.10 -

More than one arrow

Description of Design Search

The mark consists of THE WORD TECENTRIQ WITH ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG UNDER IT. THE FIRST T IN TECENTRIQ HAS THREE ARROWS POINTING INWARDS IN A CIRCLE ABOVE IT IN THE UPPER LEFT HAND CORNER.

Legal History


Status DateAction Taken
22nd Sep 2016ABANDONMENT - EXPRESS MAILED
22nd Sep 2016ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
21st Sep 2016TEAS EXPRESS ABANDONMENT RECEIVED
29th Mar 2016NON-FINAL ACTION E-MAILED
29th Mar 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
29th Mar 2016NON-FINAL ACTION WRITTEN
27th Mar 2016ASSIGNED TO EXAMINER
23rd Dec 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
22nd Dec 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
19th Dec 2015NEW APPLICATION ENTERED IN TRAM